To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BCAT2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
444 supporting clones for gene BCAT2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG674946 skin .a 1 to 724 1 to 731   tiling clone,   731/882
(82 %)
22 diff
(97.6 %id)
CR613942 B cells (Ramos cell line) Cot 25-normalized .a 218 to 1884 1 to 1667   tiling clone,   1667/1667
(100 %)
0 diff
(100 %id)
AL558311 T cells from T cell leukemia .a 218 to 922 1 to 705   fully sequenced,   705/705
(100 %)
5 diff
(99.3 %id)
AL580161 T cells from T cell leukemia .a 892 to 1886 813 to 1   fully sequenced,   671/671
(100 %)
32 diff
(95.3 %id)
AL582591 B cells from Burkitt lymphoma .a 1052 to 1884 837 to 1       837/841
(99 %)
8 diff
(99.1 %id)
NR_028451.1   .b 1 to 1631 1 to 1631 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1631/1631
(100 %)
0 diff
(100 %id)
CR618244 Neuroblastoma Cot 25-normalized .b 6 to 1584 1 to 1579       1579/1579
(100 %)
0 diff
(100 %id)
AL527821 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 6 to 815 1 to 809   fully sequenced,   809/809
(100 %)
3 diff
(99.7 %id)
BX393974 Neuroblastoma Cot 25-normalized .b 34 to 775 1 to 742       742/752
(98 %)
16 diff
(97.9 %id)
AL519216 brain, neuroblastoma, neuroblastoma cells .b 46 to 851 1 to 805   fully sequenced,   805/805
(100 %)
2 diff
(99.8 %id)
CR616057 Neuroblastoma Cot 10-normalized .b 49 to 1595 1 to 1547       1547/1547
(100 %)
0 diff
(100 %id)
AL522855 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 49 to 824 1 to 774   fully sequenced,   774/774
(100 %)
10 diff
(98.8 %id)
BU848836 ovary, teratocarcinoma, cell line .b 49 to 913 15 to 891       877/979
(89 %)
19 diff
(98.1 %id)
BU848851 ovary, teratocarcinoma, cell line .b 49 to 927 16 to 897       882/942
(93 %)
14 diff
(98.6 %id)
BU856102 ovary, teratocarcinoma, cell line .b 49 to 791 25 to 772       748/935
(80 %)
12 diff
(98.8 %id)
BU856129 ovary, teratocarcinoma, cell line .b 55 to 785 31 to 764       734/987
(74 %)
13 diff
(98.7 %id)
BU553964 ovary, teratocarcinoma, cell line .b 58 to 929 1 to 876       876/880
(99 %)
6 diff
(99.4 %id)
BU931132 ovary, teratocarcinoma, cell line .b 58 to 851 1 to 805       805/945
(85 %)
22 diff
(97.7 %id)
CR613494 Neuroblastoma Cot 25-normalized .b 60 to 1594 1 to 1535       1535/1535
(100 %)
0 diff
(100 %id)
AL525856 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 60 to 815 1 to 753   fully sequenced,   753/753
(100 %)
2 diff
(99.8 %id)
AL712824 human skeletal muscle .b 66 to 589 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
AL525101 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 70 to 759 1 to 690   fully sequenced,   690/690
(100 %)
3 diff
(99.6 %id)
CR597502 Neuroblastoma Cot 25-normalized .b 71 to 1610 1 to 1540       1540/1540
(100 %)
0 diff
(100 %id)
AL524136 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 73 to 986 1 to 910   fully sequenced,   910/910
(100 %)
13 diff
(98.6 %id)
CR615889 Neuroblastoma Cot 25-normalized .b 74 to 1612 1 to 1539       1539/1539
(100 %)
0 diff
(100 %id)
AA341064 Kidney .b 75 to 465 1 to 394       394/394
(100 %)
8 diff
(98.0 %id)
BE614960 adenocarcinoma, Pancreas .b 75 to 785 1 to 713       713/973
(73 %)
12 diff
(98.8 %id)
BE563556 adenocarcinoma, Pancreas .b 77 to 868 1 to 781       781/970
(80 %)
27 diff
(97.3 %id)
AL525100 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 729 to 1610 882 to 1   fully sequenced,   882/882
(100 %)
15 diff
(98.3 %id)
AL525816 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 754 to 1594 839 to 1   fully sequenced,   839/839
(100 %)
4 diff
(99.6 %id)
AL562985 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 754 to 1581 829 to 4   fully sequenced,   826/829
(99 %)
1 diff
(99.9 %id)
BX350921 Neuroblastoma Cot 25-normalized .b 785 to 1562 787 to 1       787/787
(100 %)
47 diff
(94.1 %id)
AL562136 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 794 to 1595 801 to 1   fully sequenced,   801/801
(100 %)
3 diff
(99.7 %id)
AL519215 brain, neuroblastoma, neuroblastoma cells .b 821 to 1559 784 to 38   fully sequenced,   628/665
(94 %)
16 diff
(97.6 %id)
AL524135 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 956 to 1601 657 to 12   fully sequenced,   646/657
(98 %)
5 diff
(99.3 %id)
AK309428 brain .c 1 to 1329 1 to 1329 exact tiling clone,   1329/1329
(100 %)
1 diff
(100.0 %id)
NM_001190.3   .d 1 to 1598 1 to 1598 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1598/1598
(100 %)
0 diff
(100 %id)
DA129578 alzheimer cortex .d 2 to 501 2 to 501   tiling clone, capped   500/500
(100 %)
0 diff
(100 %id)
BP253937 Kidney .d 2 to 582 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA899657 skeletal muscle .d 7 to 552 2 to 547   capped   546/546
(100 %)
3 diff
(99.5 %id)
BU178552 melanotic melanoma, skin .d 20 to 536 24 to 545       522/786
(66 %)
12 diff
(98.5 %id)
BP306905   .d 20 to 600 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP225149   .d 31 to 617 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
BF673375 Prostate .d 34 to 703 1 to 667       666/896
(74 %)
35 diff
(96.1 %id)
AK223522   .d 35 to 1594 24 to 1583 K73N tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1560/1583
(98 %)
7 diff
(99.6 %id)
AK314548 heart .d 35 to 1235 1 to 1201 exact     1201/1201
(100 %)
0 diff
(100 %id)
CB127809 cervix, Uterine .d 35 to 572 1 to 538       538/538
(100 %)
5 diff
(99.1 %id)
BP225240   .d 35 to 616 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP255583 Kidney .d 35 to 617 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BP256925 Kidney .d 35 to 606 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
AU099666   .d 35 to 297 36 to 298       263/298
(88 %)
6 diff
(98.0 %id)
BP273889   .d 35 to 612 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
CB139163 Liver .d 35 to 542 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BP327002 prostata .d 35 to 616 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP326651 prostata .d 35 to 617 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP326941 prostata .d 35 to 584 1 to 553       553/581
(95 %)
27 diff
(95.4 %id)
BP326977 prostata .d 35 to 616 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP328564 rectum .d 35 to 617 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP328598 rectum .d 35 to 615 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA003112   .d 36 to 582 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA016604 adrenal gland .d 36 to 605 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA068409 cerebellum .d 36 to 603 2 to 569   capped   568/570
(99 %)
2 diff
(99.7 %id)
DA080424 cerebellum .d 36 to 597 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA425133 colon .d 36 to 564 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA425343 colon .d 36 to 598 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA537971 Kidney .d 36 to 608 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA563072 heart .d 36 to 593 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA588841 lung .d 36 to 603 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BP265128 umbilical vein .d 36 to 758 1 to 729       729/924
(78 %)
14 diff
(98.5 %id)
DA667761 esophagus .d 36 to 606 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA667966 esophagus .d 36 to 581 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA680817 ovary .d 36 to 595 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA681769 ovary .d 36 to 595 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA845064 placenta .d 36 to 594 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM760815 lymph node, stomach .d 36 to 303 1 to 268       268/268
(100 %)
0 diff
(100 %id)
BM764328 lymph node, stomach .d 36 to 443 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
DB010706 colon, tumor tissue .d 36 to 605 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB031761 testis .d 36 to 617 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB190522 lung, tumor tissue .d 36 to 626 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DB190684 lung, tumor tissue .d 36 to 601 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB191244 lung, tumor tissue .d 36 to 618 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AU142856   .d 36 to 560 2 to 527   capped   526/526
(100 %)
3 diff
(99.5 %id)
DB481258 hippocampus .d 37 to 476 1 to 440       440/440
(100 %)
3 diff
(99.4 %id)
DA038497   .d 38 to 612 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA075788 cerebellum .d 38 to 620 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA101093 cerebellum .d 38 to 577 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA369122 subthalamic nucleus .d 38 to 617 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA428268 colon .d 38 to 600 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA527682 brain .d 38 to 596 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AU139539 placenta .d 38 to 731 2 to 699   capped   698/698
(100 %)
7 diff
(99.0 %id)
DA846342 placenta .d 38 to 431 2 to 397   capped   396/396
(100 %)
4 diff
(99.0 %id)
DB189253 lung, tumor tissue .d 38 to 592 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DB190703 lung, tumor tissue .d 38 to 566 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
TI_57170868   .d 39 to 915 18 to 901       884/902
(98 %)
19 diff
(97.9 %id)
DB058994 testis .d 39 to 572 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
AL702720 human skeletal muscle .d 40 to 290 1 to 251       251/251
(100 %)
1 diff
(99.7 %id)
BP257560 heart .d 41 to 621 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA433459 tongue, tumor tissue .d 42 to 841 2 to 805   capped   804/805
(99 %)
16 diff
(98.1 %id)
BC001900 Lung, small cell carcinoma .d 44 to 1587 1 to 1544 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1544/1544
(100 %)
0 diff
(100 %id)
BI115998 lung, small cell carcinoma .d 44 to 787 1 to 745       745/745
(100 %)
4 diff
(99.5 %id)
BU159216 eye, retinoblastoma .d 45 to 799 24 to 783       760/897
(84 %)
13 diff
(98.6 %id)
DN997154 breast cancer, Mammary gland (cancer tissue) .d 45 to 546 8 to 507       500/507
(98 %)
7 diff
(98.7 %id)
BQ063858 lymph, lymphoma, cell line .d 46 to 755 1 to 722       722/1069
(67 %)
17 diff
(98.5 %id)
BQ065262 lymph, lymphoma, cell line .d 46 to 896 1 to 853       853/983
(86 %)
9 diff
(99.1 %id)
BQ065811 lymph, lymphoma, cell line .d 46 to 894 1 to 857       857/1029
(83 %)
11 diff
(99.0 %id)
BQ642064 lymph, lymphoma, cell line .d 46 to 964 1 to 926       926/927
(99 %)
22 diff
(97.7 %id)
TI_57236585   .d 47 to 941 21 to 926       906/987
(91 %)
25 diff
(97.5 %id)
BG748672 eye, normal pigmented retinal epithelium .d 48 to 914 1 to 869       869/871
(99 %)
26 diff
(97.1 %id)
BG748591 eye, normal pigmented retinal epithelium .d 48 to 818 1 to 771       771/771
(100 %)
4 diff
(99.5 %id)
BG751031 eye, normal pigmented retinal epithelium .d 48 to 916 1 to 875       875/875
(100 %)
16 diff
(98.2 %id)
BG752039 eye, normal pigmented retinal epithelium .d 48 to 894 1 to 882       741/934
(79 %)
38 diff
(96.0 %id)
CR605733 HeLa cells Cot 25-normalized .d 49 to 1559 1 to 1511 exact     1511/1511
(100 %)
0 diff
(100 %id)
CR620275 HeLa cells Cot 25-normalized .d 49 to 1566 1 to 1518 exact     1518/1518
(100 %)
0 diff
(100 %id)
BX362326   .d 49 to 359 1 to 311       311/311
(100 %)
0 diff
(100 %id)
AL556262 placenta .d 49 to 981 1 to 931       931/935
(99 %)
9 diff
(99.1 %id)
BX365564   .d 49 to 985 1 to 930       930/1031
(90 %)
14 diff
(98.7 %id)
AL556346 placenta .d 49 to 925 1 to 874   fully sequenced,   874/874
(100 %)
2 diff
(99.8 %id)
BU557380 ovary, teratocarcinoma, cell line .d 49 to 877 1 to 838       838/864
(96 %)
10 diff
(98.9 %id)
BM050520 eye, normal pigmented retinal epithelium .d 50 to 896 1 to 863       863/963
(89 %)
15 diff
(98.5 %id)
BQ072529 pooled lung and spleen .d 50 to 758 71 to 788       718/1136
(63 %)
31 diff
(97.3 %id)
CR618489 fetal liver .d 51 to 1542 1 to 1492 exact     1492/1492
(100 %)
0 diff
(100 %id)
BX380969 Placenta Cot 25-normalized .d 51 to 587 1 to 538       538/725
(74 %)
3 diff
(99.6 %id)
BX448305 fetal liver, Liver .d 51 to 894 1 to 843       843/926
(91 %)
3 diff
(99.7 %id)
BG742641 skin .d 51 to 915 1 to 867       867/867
(100 %)
5 diff
(99.5 %id)
BI160715 epithelioid carcinoma cell line, Pancreas .d 51 to 710 1 to 662       662/662
(100 %)
7 diff
(99.0 %id)
BI193714 epithelioid carcinoma cell line, Pancreas .d 51 to 587 1 to 551       551/763
(72 %)
24 diff
(96.9 %id)
BM044547 carcinoma, cell line, Prostate .d 51 to 856 1 to 800       800/800
(100 %)
8 diff
(99.0 %id)
BM903756 ovary (pool of 3) .d 51 to 981 12 to 944       933/1033
(90 %)
11 diff
(99.0 %id)
BU557054 ovary, teratocarcinoma, cell line .d 51 to 969 1 to 928       926/946
(97 %)
17 diff
(98.3 %id)
TI_57217154   .d 51 to 718 67 to 734       668/734
(91 %)
6 diff
(99.2 %id)
TI_57220280   .d 51 to 892 35 to 880       846/907
(93 %)
30 diff
(96.7 %id)
TI_57197512   .d 51 to 894 34 to 877       844/961
(87 %)
19 diff
(98.1 %id)
TI_57199433   .d 51 to 985 36 to 975       940/998
(94 %)
30 diff
(97.0 %id)
TI_57237079   .d 51 to 587 40 to 579       540/755
(71 %)
16 diff
(97.9 %id)
AF268047 placenta .d 52 to 1596 1 to 1545 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1545/1545
(100 %)
0 diff
(100 %id)
CR609900 Placenta Cot 25-normalized .d 52 to 1537 1 to 1486 exact     1486/1486
(100 %)
0 diff
(100 %id)
CR619463 Placenta Cot 25-normalized .d 52 to 1530 1 to 1479 exact     1479/1479
(100 %)
0 diff
(100 %id)
BX366587 Placenta Cot 25-normalized .d 52 to 925 1 to 874   fully sequenced,   874/874
(100 %)
2 diff
(99.8 %id)
AL548608 placenta, Placenta Cot 25-normalized .d 52 to 782 1 to 727   fully sequenced,   727/727
(100 %)
0 diff
(100 %id)
BX340880   .d 52 to 752 1 to 702       702/756
(92 %)
19 diff
(97.5 %id)
BX344487   .d 52 to 945 1 to 890       890/890
(100 %)
4 diff
(99.6 %id)
BX342865   .d 52 to 359 1 to 308       308/308
(100 %)
0 diff
(100 %id)
AL561350 B cells from Burkitt lymphoma .d 52 to 893 1 to 837       837/837
(100 %)
41 diff
(95.2 %id)
AW732881 choriocarcinoma, placenta .d 52 to 536 1 to 485       485/485
(100 %)
6 diff
(98.8 %id)
BU178066 melanotic melanoma, skin .d 52 to 838 1 to 793       793/846
(93 %)
7 diff
(99.2 %id)
TI_57218582   .d 52 to 881 31 to 864       834/865
(96 %)
35 diff
(96.0 %id)
TI_57183877   .d 52 to 894 26 to 868       843/868
(97 %)
13 diff
(98.6 %id)
BX417532 placenta .d 53 to 1091 1 to 1030       1030/1030
(100 %)
23 diff
(97.8 %id)
BQ940590 eye, normal pigmented retinal epithelium .d 53 to 882 1 to 849       847/911
(92 %)
9 diff
(99.1 %id)
BU541284 carcinoma, cell line, Prostate .d 53 to 936 1 to 887       887/887
(100 %)
11 diff
(98.8 %id)
BU542383 carcinoma, cell line, Prostate .d 53 to 900 1 to 855       855/863
(99 %)
10 diff
(98.9 %id)
CR600705 HeLa cells Cot 25-normalized .d 54 to 1563 1 to 1510 exact     1510/1510
(100 %)
0 diff
(100 %id)
AL555881 placenta .d 54 to 782 1 to 727   fully sequenced,   727/727
(100 %)
2 diff
(99.8 %id)
TI_57197995   .d 55 to 892 30 to 865       836/869
(96 %)
22 diff
(97.5 %id)
BG698436 skin .d 56 to 765 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BG761991 melanotic melanoma, high MDR (cell line), skin .d 56 to 763 1 to 708       708/709
(99 %)
2 diff
(99.8 %id)
BG763631 melanotic melanoma, high MDR (cell line), skin .d 56 to 936 1 to 880       880/884
(99 %)
4 diff
(99.6 %id)
TI_1948076951   .d 56 to 782 133 to 860   fully sequenced,   728/860
(84 %)
6 diff
(99.4 %id)
TI_1948077117   .d 56 to 782 133 to 859   fully sequenced,   727/859
(84 %)
6 diff
(99.4 %id)
TI_1948077290   .d 56 to 782 139 to 865   fully sequenced,   727/865
(84 %)
6 diff
(99.4 %id)
TI_1948077460   .d 56 to 618 132 to 694   fully sequenced,   563/694
(81 %)
6 diff
(99.2 %id)
CR594438 Neuroblastoma Cot 25-normalized .d 57 to 1550 1 to 1494 exact     1494/1494
(100 %)
0 diff
(100 %id)
CR599031 HeLa cells Cot 25-normalized .d 57 to 1568 1 to 1512 exact     1512/1512
(100 %)
0 diff
(100 %id)
CR619213 T cells (Jurkat cell line) Cot10-normalized .d 57 to 1562 1 to 1506 exact     1506/1506
(100 %)
0 diff
(100 %id)
CR621349 Placenta Cot 25-normalized .d 57 to 1570 1 to 1514 exact     1514/1514
(100 %)
0 diff
(100 %id)
CR626800 Placenta Cot 25-normalized .d 57 to 1564 1 to 1508 exact     1508/1508
(100 %)
0 diff
(100 %id)
AL526981 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 57 to 838 1 to 781   fully sequenced,   781/781
(100 %)
2 diff
(99.8 %id)
BX324638 Placenta Cot 25-normalized .d 57 to 925 1 to 867   fully sequenced,   867/867
(100 %)
2 diff
(99.8 %id)
BX365087 Placenta Cot 25-normalized .d 57 to 1055 1 to 984       984/997
(98 %)
19 diff
(98.1 %id)
BX380226 Placenta Cot 25-normalized .d 57 to 467 1 to 411       411/411
(100 %)
0 diff
(100 %id)
AL559112 T cells from T cell leukemia .d 57 to 782 1 to 723   fully sequenced,   723/723
(100 %)
7 diff
(99.1 %id)
AL556486 placenta .d 57 to 838 1 to 778   fully sequenced,   778/778
(100 %)
1 diff
(99.9 %id)
CV025913 mixed .d 57 to 653 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
TI_57181956   .d 57 to 915 33 to 893       861/894
(96 %)
13 diff
(98.6 %id)
U68418   .d 57 to 1597 1 to 1541 T186R     1541/1546
(99 %)
4 diff
(99.8 %id)
BF307884 muscle, rhabdomyosarcoma .d 58 to 752 1 to 706       706/1062
(66 %)
33 diff
(96.9 %id)
BI114498 muscle, rhabdomyosarcoma .d 58 to 866 1 to 825       825/918
(89 %)
33 diff
(96.5 %id)
TI_57200142   .d 58 to 814 69 to 826       758/826
(91 %)
9 diff
(99.0 %id)
D31379   .d 59 to 279 1 to 221       221/230
(96 %)
2 diff
(99.2 %id)
BG394098 eye, retinoblastoma .d 59 to 752 1 to 689       689/927
(74 %)
9 diff
(99.1 %id)
BG480512 choriocarcinoma, placenta .d 59 to 854 1 to 794       794/794
(100 %)
12 diff
(98.5 %id)
BG748499 eye, normal pigmented retinal epithelium .d 59 to 983 1 to 915       915/916
(99 %)
16 diff
(98.3 %id)
BI116935 lung, small cell carcinoma .d 59 to 885 1 to 844       844/849
(99 %)
33 diff
(96.2 %id)
BM921922 pooled brain, lung, testis .d 59 to 896 7 to 848       842/1019
(82 %)
10 diff
(99.1 %id)
BU164471 epithelioid carcinoma, Pancreas .d 59 to 894 1 to 839       839/893
(93 %)
10 diff
(98.9 %id)
CB265362 adipose .d 60 to 582 1 to 522       522/522
(100 %)
8 diff
(98.5 %id)
CN260694 embryonic stem cells, cell lines H1, H7, andH9 .d 60 to 661 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
CA395146 eye, RPE/choroid .d 60 to 541 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
BE266710 lung, small cell carcinoma .d 60 to 630 1 to 585       582/746
(78 %)
26 diff
(96.6 %id)
BI772746 pooled lung and spleen .d 60 to 826 27 to 792       766/792
(96 %)
6 diff
(99.3 %id)
BM926301 brain .d 60 to 740 25 to 709       685/1032
(66 %)
13 diff
(98.8 %id)
TI_57178174   .d 60 to 826 27 to 792       766/792
(96 %)
6 diff
(99.3 %id)
TI_57237411   .d 60 to 889 35 to 877       843/904
(93 %)
44 diff
(95.2 %id)
BU154466 eye, retinoblastoma .d 61 to 895 1 to 849       849/904
(93 %)
22 diff
(97.6 %id)
BQ929629 leiomyosarcoma, uterus .d 61 to 965 1 to 906       906/914
(99 %)
9 diff
(99.1 %id)
BG674520 skin .d 62 to 894 1 to 851       851/910
(93 %)
25 diff
(97.3 %id)
BG696862 skin .d 62 to 751 1 to 687       687/687
(100 %)
6 diff
(99.2 %id)
BQ067485 pooled brain, lung, testis .d 62 to 844 20 to 810       791/1102
(71 %)
25 diff
(97.8 %id)
CX759049 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 62 to 755 39 to 730     Submitted on the opposite strand 692/867
(79 %)
12 diff
(98.7 %id)
BE265081 lung, small cell carcinoma .d 63 to 752 1 to 681       681/722
(94 %)
18 diff
(97.6 %id)
BQ218944 leiomyosarcoma, uterus .d 63 to 987 1 to 935       935/1006
(92 %)
25 diff
(97.6 %id)
BE264265 lung, small cell carcinoma .d 72 to 563 1 to 492       492/493
(99 %)
1 diff
(99.8 %id)
BM020463 astrocytoma grade IV, cell line, brain .d 72 to 882 2 to 812       811/812
(99 %)
10 diff
(98.8 %id)
TI_59391250   .d 72 to 882 96 to 906       811/811
(100 %)
10 diff
(98.8 %id)
BM558091 astrocytoma grade IV, cell line, brain .d 73 to 894 1 to 825       825/967
(85 %)
10 diff
(99.0 %id)
CX755084 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 73 to 728 1 to 650     Submitted on the opposite strand 650/728
(89 %)
26 diff
(96.5 %id)
CR599073 HeLa cells Cot 25-normalized .d 78 to 1583 1 to 1506       1506/1506
(100 %)
0 diff
(100 %id)
CR607392 T cells (Jurkat cell line) Cot10-normalized .d 78 to 1570 1 to 1493       1493/1493
(100 %)
0 diff
(100 %id)
CR617166 HeLa cells Cot 25-normalized .d 78 to 1541 1 to 1464       1464/1464
(100 %)
0 diff
(100 %id)
AL527581 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 78 to 356 1 to 278       278/278
(100 %)
0 diff
(100 %id)
AL559592 T cells from T cell leukemia .d 78 to 795 1 to 711   fully sequenced,   711/711
(100 %)
3 diff
(99.6 %id)
AL583667 placenta .d 78 to 838 1 to 765   fully sequenced,   765/765
(100 %)
2 diff
(99.8 %id)
AL583665 placenta .d 78 to 925 1 to 844   fully sequenced,   844/844
(100 %)
6 diff
(99.3 %id)
CR621640 B cells (Ramos cell line) Cot 25-normalized .d 79 to 1549 1 to 1471       1471/1471
(100 %)
0 diff
(100 %id)
BE259448 eye, retinoblastoma .d 79 to 751 1 to 672       672/723
(92 %)
10 diff
(98.7 %id)
TI_1948077461   .d 557 to 1234 800 to 124   fully sequenced,   677/800
(84 %)
0 diff
(100 %id)
AL562934 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 586 to 1553 975 to 15       961/1072
(89 %)
11 diff
(99.0 %id)
AL573176 placenta, Placenta Cot 25-normalized .d 721 to 1530 805 to 1   fully sequenced,   805/805
(100 %)
5 diff
(99.4 %id)
AL580802 T cells from T cell leukemia .d 721 to 1562 841 to 1   fully sequenced,   841/841
(100 %)
3 diff
(99.7 %id)
AL578268 placenta .d 721 to 1563 843 to 1   fully sequenced,   843/843
(100 %)
2 diff
(99.8 %id)
TI_1948076952   .d 721 to 1234 642 to 129   fully sequenced,   514/642
(80 %)
0 diff
(100 %id)
TI_1948077118   .d 721 to 1234 642 to 129   fully sequenced,   514/642
(80 %)
0 diff
(100 %id)
TI_1948077291   .d 721 to 1234 641 to 128   fully sequenced,   514/641
(80 %)
0 diff
(100 %id)
TI_227714936   .d 751 to 1594 955 to 113   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 843/997
(84 %)
9 diff
(99.1 %id)
BM693895 eye, lens .d 754 to 1227 1 to 474   fully sequenced,   474/474
(100 %)
0 diff
(100 %id)
AL581184 T cells from T cell leukemia .d 765 to 1563 803 to 7   fully sequenced,   797/803
(99 %)
12 diff
(98.6 %id)
AI209054 Kidney .d 766 to 1594 827 to 1       827/828
(99 %)
27 diff
(96.8 %id)
AL526940 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 808 to 1550 743 to 1   fully sequenced,   743/743
(100 %)
1 diff
(99.9 %id)
AL578936 placenta .d 808 to 1541 734 to 1   fully sequenced,   734/734
(100 %)
0 diff
(100 %id)
AL578729 placenta .d 808 to 1568 761 to 1   fully sequenced,   761/761
(100 %)
0 diff
(100 %id)
TI_154036104   .d 826 to 1594 843 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 760/927
(81 %)
9 diff
(99.1 %id)
TI_159705698   .d 826 to 1594 891 to 132   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 760/917
(82 %)
13 diff
(98.6 %id)
AI972689 Prostate .d 837 to 1597 764 to 5       760/764
(99 %)
14 diff
(98.2 %id)
BG287133 bladder, transitional cell papilloma, cell line .d 837 to 1532 1 to 689       689/955
(72 %)
10 diff
(99.0 %id)
BI083925 epidermoid carcinoma, cell line, salivary gland .d 843 to 1580 1 to 740   fully sequenced,   740/740
(100 %)
12 diff
(98.4 %id)
CD676108 eye, lens .d 851 to 1465 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BX324637 Placenta Cot 25-normalized .d 864 to 1564 702 to 1   fully sequenced,   702/702
(100 %)
4 diff
(99.5 %id)
BX366586 Placenta Cot 25-normalized .d 864 to 1526 676 to 12   fully sequenced,   665/676
(98 %)
1 diff
(99.9 %id)
AL578629 placenta .d 864 to 1566 703 to 1   fully sequenced,   703/703
(100 %)
3 diff
(99.6 %id)
AL578491 placenta .d 864 to 1538 719 to 43   fully sequenced,   677/719
(94 %)
2 diff
(99.8 %id)
CB250680 Human Lung Epithelial cells, lung .d 873 to 1594 735 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 720/720
(100 %)
2 diff
(99.8 %id)
CA428885 Bone, Subchondral Bone .d 873 to 1596 740 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 722/722
(100 %)
2 diff
(99.8 %id)
BU633443 cell lines, Chondrosarcoma .d 873 to 1594 739 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 721/721
(100 %)
1 diff
(99.9 %id)
CA425913 cell lines, Chondrosarcoma .d 874 to 1594 731 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 720/720
(100 %)
3 diff
(99.6 %id)
CA444333 lung, Metastatic Chondrosarcoma .d 876 to 1594 731 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 716/716
(100 %)
3 diff
(99.6 %id)
CA418463 Chondrosarcoma Grade II, Left Pelvis .d 878 to 1594 738 to 24   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 715/718
(99 %)
2 diff
(99.8 %id)
BQ014308 Chondrosarcoma, Left Pubic Bone .d 879 to 1596 733 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 717/717
(100 %)
1 diff
(99.9 %id)
BQ008453 Chondrosarcoma, Left Pubic Bone .d 880 to 1596 732 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 716/716
(100 %)
1 diff
(99.9 %id)
TI_149292689   .d 884 to 1596 792 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 709/709
(100 %)
4 diff
(99.5 %id)
CD365534 Alveolar Macrophage, lung .d 885 to 1594 722 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 711/711
(100 %)
1 diff
(99.9 %id)
BX393334   .d 894 to 1529 645 to 4       642/793
(80 %)
26 diff
(96.8 %id)
BX448304 fetal liver, Liver .d 894 to 1542 650 to 1       650/946
(68 %)
2 diff
(99.8 %id)
AI936997 anaplastic oligodendroglioma, brain .d 894 to 1597 722 to 20       703/737
(95 %)
11 diff
(98.6 %id)
AI972636 Prostate .d 894 to 1597 708 to 5       704/717
(98 %)
5 diff
(99.4 %id)
CB241585 Human Lung Epithelial cells, lung .d 894 to 1594 714 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 699/706
(99 %)
2 diff
(99.8 %id)
AW081319 colon, moderately differentiated adenocarcinoma .d 897 to 1596 724 to 23   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 702/702
(100 %)
23 diff
(96.8 %id)
BM974758 lung .d 907 to 1596 704 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 688/688
(100 %)
2 diff
(99.8 %id)
AI991298 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 913 to 1595 689 to 6       684/690
(99 %)
9 diff
(98.7 %id)
BF445893 Prostate .d 919 to 1597 676 to 5       673/683
(98 %)
20 diff
(97.1 %id)
EL951820 eyeball .d 928 to 1536 1 to 610       610/610
(100 %)
6 diff
(99.1 %id)
BM697942 eye, fetal eyes .d 932 to 1456 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
AA524930   .d 936 to 1312 452 to 76       377/458
(82 %)
0 diff
(100 %id)
BU162281 melanotic melanoma, cell line, skin .d 939 to 1587 1 to 649   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BM793348 Ascites, stomach .d 973 to 1582 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
BM797796 Ascites, stomach .d 973 to 1374 1 to 402       402/402
(100 %)
0 diff
(100 %id)
CA314219 Human Lung Epithelial cells, lung .d 973 to 1598 642 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 626/642
(97 %)
0 diff
(100 %id)
BE139200 lung, two pooled squamous cell carcinomas .d 975 to 1599 624 to 1       624/624
(100 %)
60 diff
(90.4 %id)
BX454483 placenta .d 980 to 1590 610 to 1       610/667
(91 %)
11 diff
(98.4 %id)
BQ189522 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 980 to 1598 7 to 625   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 619/625
(99 %)
6 diff
(99.1 %id)
TI_151710113   .d 980 to 1594 716 to 102   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 615/1038
(59 %)
10 diff
(99.1 %id)
TI_151734034   .d 980 to 1598 723 to 102   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 622/905
(68 %)
11 diff
(98.8 %id)
CK902630 insulinoma, Pancreas .d 987 to 1584 597 to 1       597/597
(100 %)
2 diff
(99.7 %id)
AA586830 colon, colon tumor RER+ .d 1002 to 1218 217 to 1       217/217
(100 %)
12 diff
(94.5 %id)
CA310873 Human Lung Epithelial cells, lung .d 1015 to 1598 603 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 585/585
(100 %)
2 diff
(99.7 %id)
BY796876 eye .d 1028 to 1531 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
CA423490 cell lines, Chondrosarcoma .d 1028 to 1594 578 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 567/567
(100 %)
5 diff
(99.2 %id)
BX374268.
matches multiple genes
  .d 1032 to 1532 513 to 7     also hits gene gawmobo 507/568
(89 %)
25 diff
(95.6 %id)
AA514608 colon .d 1033 to 1598 567 to 1       567/574
(98 %)
5 diff
(99.2 %id)
AA661640 normal prostate, Prostate .d 1036 to 1596 559 to 1       559/560
(99 %)
28 diff
(95.0 %id)
TI_154124743   .d 1040 to 1598 630 to 77   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 554/869
(63 %)
30 diff
(96.6 %id)
AU160056   .d 1042 to 1594 555 to 1       555/556
(99 %)
12 diff
(97.9 %id)
BU632425 cell lines, Chondrosarcoma .d 1048 to 1594 562 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 547/547
(100 %)
2 diff
(99.7 %id)
BE677934 pooled .d 1056 to 1595 547 to 8       540/547
(98 %)
5 diff
(99.1 %id)
AA481353 ovarian tumor, ovary .d 1058 to 1219 1 to 162   fully sequenced,   162/162
(100 %)
3 diff
(98.2 %id)
CB049110 Prostate .d 1061 to 1594 576 to 43   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 534/534
(100 %)
7 diff
(98.7 %id)
TI_154054167   .d 1073 to 1596 667 to 138   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 530/919
(57 %)
26 diff
(97.2 %id)
BM795589 stomach .d 1078 to 1517 1 to 440       440/440
(100 %)
0 diff
(100 %id)
AI299059 2 pooled tumors (clear cell type), Kidney .d 1083 to 1595 515 to 3       513/515
(99 %)
3 diff
(99.5 %id)
BE407891 choriocarcinoma, placenta .d 1090 to 1423 1 to 334       334/334
(100 %)
10 diff
(97.1 %id)
BI084595 epidermoid carcinoma, cell line, salivary gland .d 1091 to 1527 450 to 14   fully sequenced,   437/450
(97 %)
0 diff
(100 %id)
CK300516 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1091 to 1598 524 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 508/508
(100 %)
1 diff
(99.9 %id)
AA652412 normal prostate, Prostate .d 1092 to 1595 511 to 8       504/511
(98 %)
1 diff
(99.9 %id)
AW023914 cochlea, ear .d 1093 to 1554 2 to 462       461/462
(99 %)
7 diff
(98.5 %id)
R97353.
matches multiple genes
liver and spleen .d 1118 to 1365 1 to 248     also hits gene NEK9 248/248
(100 %)
7 diff
(97.2 %id)
AI916171 colon, colon tumor, RER+ .d 1124 to 1593 469 to 1       469/539
(87 %)
8 diff
(98.6 %id)
AA530899 normal prostate, Prostate .d 1130 to 1594 496 to 32   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 465/466
(99 %)
0 diff
(100 %id)
AI831302 lymph node, lymphoma, follicular mixed small and largecell .d 1134 to 1594 466 to 6       461/466
(98 %)
1 diff
(99.8 %id)
BQ029679 lung, Metastatic Chondrosarcoma .d 1139 to 1595 474 to 18       457/474
(96 %)
0 diff
(100 %id)
BU783991 insulinoma, Pancreas .d 1139 to 1594 474 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
AW007792 colon .d 1143 to 1597 456 to 2       455/456
(99 %)
0 diff
(100 %id)
BU558137 adenocarcinoma, cell line, breast .d 1161 to 1591 1 to 432   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 432/432
(100 %)
1 diff
(99.8 %id)
BU856740 adenocarcinoma, cell line, breast .d 1161 to 1587 1 to 427   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
BU860243 adenocarcinoma, cell line, breast .d 1161 to 1587 1 to 427   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
AA436410 ovarian tumor, ovary .d 1166 to 1595 437 to 8   fully sequenced,   430/437
(98 %)
0 diff
(100 %id)
BM670956 eye, lens .d 1166 to 1595 444 to 15   fully sequenced,   430/444
(96 %)
0 diff
(100 %id)
BE301356 choriocarcinoma, placenta .d 1168 to 1595 436 to 9       428/436
(98 %)
0 diff
(100 %id)
AA523144 metastatic prostate bone lesion .d 1191 to 1583 1 to 392   AAA   392/403
(97 %)
6 diff
(98.6 %id)
AA625126 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1193 to 1588 1 to 394       394/394
(100 %)
4 diff
(99.0 %id)
AW972683   .d 1198 to 1601 111 to 514       404/526
(76 %)
5 diff
(99.1 %id)
DB300392.
matches multiple genes
cerebellum .d 1200 to 1598 399 to 1     also hits gene kakiya 399/399
(100 %)
2 diff
(99.5 %id)
BG402642 bladder, transitional cell papilloma, cell line .d 1213 to 1596 1 to 383   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 383/383
(100 %)
2 diff
(99.5 %id)
CA415850 Chondrosarcoma Cell line .d 1217 to 1598 397 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 381/381
(100 %)
2 diff
(99.5 %id)
DB379914 placenta .d 1240 to 1596 359 to 1       359/359
(100 %)
15 diff
(95.9 %id)
BP429265   .d 1241 to 1584 1 to 344       344/344
(100 %)
0 diff
(100 %id)
AA635768 normal prostate, Prostate .d 1250 to 1596 348 to 1       348/348
(100 %)
3 diff
(99.2 %id)
AI370621   .d 1315 to 1599 287 to 3       285/287
(99 %)
0 diff
(100 %id)
AI500287 anaplastic oligodendroglioma, brain .d 1315 to 1597 302 to 20       283/302
(93 %)
0 diff
(100 %id)
AI362367 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1327 to 1595 271 to 3       269/271
(99 %)
0 diff
(100 %id)
BF726632 eye, lens .d 1363 to 1597 1 to 236       236/237
(99 %)
4 diff
(98.4 %id)
AI612793 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1436 to 1595 181 to 22       160/181
(88 %)
0 diff
(100 %id)
AI824200 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1465 to 1598 134 to 1       134/135
(99 %)
1 diff
(99.3 %id)
AW246851 lung, small cell carcinoma .d 1508 to 1595 97 to 10       88/97
(90 %)
0 diff
(100 %id)
DB119338 thymus .e 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
AU121538 mammary gland .e 3 to 822 2 to 821   tiling clone, capped   818/820
(99 %)
8 diff
(99.1 %id)
DA165406 amygdala .e 94 to 662 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AU147328 mammary gland .e 1583 to 2117 536 to 1   tiling clone,   536/536
(100 %)
10 diff
(98.2 %id)
NR_028450.1   .f 1 to 2078 2 to 2079 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2079/2079
(100 %)
0 diff
(100 %id)
BM802402 eye, retinoblastoma .f 26 to 947 1 to 930       930/933
(99 %)
14 diff
(98.5 %id)
DA631026 Kidney .f 32 to 612 2 to 582   capped   581/581
(100 %)
5 diff
(99.2 %id)
DA586307 lung .f 35 to 622 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA591089 lung .f 35 to 573 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DB136842 thymus .f 35 to 557 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
AK093627 thymus .f 36 to 2076 14 to 2054 exact available from FLJ,   2041/2041
(100 %)
3 diff
(99.9 %id)
DB104612 thymus .f 36 to 580 14 to 558   capped   545/558
(97 %)
8 diff
(98.6 %id)
DA745157   .f 50 to 612 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB193533 ovary, tumor tissue .f 233 to 811 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BE407568 choriocarcinoma, placenta .f 558 to 1235 10 to 686       677/742
(91 %)
31 diff
(95.9 %id)
AL582932 B cells from Burkitt lymphoma .f 559 to 1318 1 to 757   fully sequenced,   757/757
(100 %)
4 diff
(99.5 %id)
BE252046 eye, retinoblastoma .f 559 to 1179 1 to 614       614/724
(84 %)
9 diff
(98.8 %id)
BU500671   .f 560 to 1375 7 to 837       831/876
(94 %)
26 diff
(97.1 %id)
BE547358 cervical carcinoma cell line, cervix .f 562 to 1108 1 to 558       560/558
(100 %)
22 diff
(96.1 %id)
BU177086 melanotic melanoma, skin .f 564 to 1375 20 to 843       824/949
(86 %)
29 diff
(97.0 %id)
TI_154188068   .f 569 to 1232 122 to 782       661/902
(73 %)
5 diff
(99.5 %id)
TI_154188092   .f 569 to 1315 121 to 859       739/926
(79 %)
13 diff
(98.6 %id)
BG763338 melanotic melanoma, high MDR (cell line), skin .f 570 to 1223 1 to 654       654/655
(99 %)
2 diff
(99.7 %id)
BG763679 melanotic melanoma, high MDR (cell line), skin .f 570 to 1287 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
BM479062 melanotic melanoma, skin .f 570 to 1461 1 to 898       898/1102
(81 %)
23 diff
(98.0 %id)
BG830926 epithelioid carcinoma cell line, Pancreas .f 571 to 1453 1 to 884       884/887
(99 %)
9 diff
(99.0 %id)
BQ962400 epithelioid carcinoma cell line, Pancreas .f 573 to 1451 1 to 883       881/888
(99 %)
22 diff
(97.6 %id)
BC004243 Skin, melanotic melanoma. .f 575 to 2067 1 to 1493 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1493/1493
(100 %)
0 diff
(100 %id)
F08191 brain, total brain .f 583 to 893 1 to 311       311/311
(100 %)
0 diff
(100 %id)
U62739 brain .f 583 to 2068 22 to 1509 V114L T146R T167N D174E A176T ...     1488/1509
(98 %)
25 diff
(98.4 %id)
BP256609 Kidney .f 584 to 1157 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
R13964 whole brain .f 584 to 947 1 to 370     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 370/413
(89 %)
17 diff
(95.9 %id)
CF140958 CNCAP(3)T-225 cell line, Prostate .f 584 to 947 8 to 371       364/379
(96 %)
11 diff
(97.1 %id)
BE384314 melanotic melanoma, skin .f 594 to 1214 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BE385169 melanotic melanoma, skin .f 595 to 1196 1 to 608   available from MGC,   608/608
(100 %)
10 diff
(98.4 %id)
BF025790 melanotic melanoma, skin .f 595 to 1354 1 to 745       745/932
(79 %)
25 diff
(97.4 %id)
H05572 whole brain .f 630 to 1092 1 to 464     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 459/464
(98 %)
17 diff
(96.4 %id)
BX372377   .f 638 to 1556 915 to 1       915/918
(99 %)
13 diff
(98.6 %id)
BG420115 Kidney, renal cell adenocarcinoma .f 663 to 1461 1 to 790       790/1030
(76 %)
25 diff
(97.6 %id)
CX866962 embryonic stem .f 688 to 1496 1 to 809       809/809
(100 %)
0 diff
(100 %id)
BQ440646 leiomyosarcoma, uterus .f 710 to 1461 11 to 764       751/924
(81 %)
28 diff
(97.0 %id)
BQ671823 epidermoid carcinoma, cell line, salivary gland .f 712 to 1467 10 to 766       754/937
(80 %)
15 diff
(98.4 %id)
BQ668614 epidermoid carcinoma, cell line, salivary gland .f 712 to 1466 17 to 784       768/967
(79 %)
22 diff
(97.8 %id)
BQ668419 epidermoid carcinoma, cell line, salivary gland .f 717 to 1298 1 to 595       595/1071
(55 %)
19 diff
(98.3 %id)
BQ672439 epidermoid carcinoma, cell line, salivary gland .f 717 to 1538 1 to 835       832/923
(90 %)
27 diff
(97.1 %id)
BE795237 lung, small cell carcinoma .f 732 to 1555 1 to 828       828/1033
(80 %)
17 diff
(98.4 %id)
CD513209 brain, Pituitary .f 758 to 1321 62 to 632       571/1243
(45 %)
24 diff
(98.1 %id)
BE790653 lung, small cell carcinoma .f 831 to 1594 10 to 775       764/929
(82 %)
23 diff
(97.6 %id)
BE264138 lung, small cell carcinoma .f 833 to 1362 9 to 542       534/542
(98 %)
5 diff
(99.1 %id)
BE884709 leiomyosarcoma, uterus .f 833 to 1465 1 to 633       633/661
(95 %)
9 diff
(98.7 %id)
BE903035 choriocarcinoma, placenta .f 836 to 1601 1 to 755       755/963
(78 %)
14 diff
(98.6 %id)
BE902452 choriocarcinoma, placenta .f 838 to 1043 1 to 210       210/235
(89 %)
10 diff
(95.8 %id)
BG436752 large cell carcinoma, lung .f 838 to 1601 1 to 764       764/893
(85 %)
6 diff
(99.4 %id)
CR998677 T-Lymphocytes .f 845 to 1461 1 to 619       619/622
(99 %)
2 diff
(99.7 %id)
BU538779 adenocarcinoma, cell line, breast .f 851 to 1584 1 to 747       747/859
(86 %)
13 diff
(98.5 %id)
BU539599 adenocarcinoma, cell line, breast .f 851 to 1602 1 to 755       755/894
(84 %)
11 diff
(98.8 %id)
BG675375 skin .f 907 to 1850 1 to 987       844/1035
(81 %)
79 diff
(92.4 %id)
BX280920 pooled lung and spleen .f 922 to 1423 1 to 502       502/502
(100 %)
0 diff
(100 %id)
BI768257 pooled lung and spleen .f 922 to 1872 1 to 949       949/962
(98 %)
18 diff
(98.2 %id)
TI_57180476   .f 922 to 1872 35 to 983       949/996
(95 %)
24 diff
(97.6 %id)
BQ326087 colon_normal .f 947 to 1231 332 to 48       285/346
(82 %)
8 diff
(97.7 %id)
BP223692 colon mucosa .f 952 to 1459 1 to 511       511/564
(90 %)
5 diff
(99.2 %id)
BX365086 Placenta Cot 25-normalized .f 955 to 2045 1083 to 1       1083/1083
(100 %)
27 diff
(97.6 %id)
BX365563   .f 976 to 2039 1051 to 1       1051/1073
(97 %)
23 diff
(97.9 %id)
EC546883 Prostate .f 1048 to 1135 89 to 5       85/91
(93 %)
1 diff
(99.0 %id)
CN260693 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1049 to 1631 1 to 583       583/587
(99 %)
2 diff
(99.7 %id)
CK902631 insulinoma, Pancreas .f 1061 to 1634 7 to 580       574/580
(98 %)
6 diff
(99.0 %id)
AL578567 placenta .f 1068 to 2039 971 to 1       971/971
(100 %)
22 diff
(97.8 %id)
AL552302.
matches multiple genes
placenta, Placenta Cot 25-normalized .f 1082 to 1461 1 to 382     also hits gene GMPS 382/387
(98 %)
18 diff
(95.4 %id)
BI253441 cervical carcinoma cell line, cervix .f 1093 to 1767 1 to 675       675/675
(100 %)
0 diff
(100 %id)
BX344486   .f 1097 to 2020 928 to 4       925/928
(99 %)
2 diff
(99.8 %id)
BG289384 bladder, transitional cell papilloma, cell line .f 1136 to 1877 1 to 735       735/739
(99 %)
12 diff
(98.4 %id)
BE903356 choriocarcinoma, placenta .f 1144 to 1904 13 to 771       759/772
(98 %)
16 diff
(98.0 %id)
BG743083 skin .f 1156 to 2073 1 to 915       915/915
(100 %)
17 diff
(98.2 %id)
BX404904 placenta .f 1168 to 2041 874 to 1       874/874
(100 %)
4 diff
(99.6 %id)
BF307565 muscle, rhabdomyosarcoma .f 1210 to 1886 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
BE741534 adenocarcinoma cell line, ovary .f 1218 to 2015 1 to 790       790/916
(86 %)
20 diff
(97.9 %id)
AA252586 germinal center B cell .f 1255 to 1439 1 to 185       185/185
(100 %)
4 diff
(97.9 %id)
AL582882 B cells from Burkitt lymphoma .f 1288 to 2012 739 to 15   fully sequenced,   725/739
(98 %)
0 diff
(100 %id)
CN260692 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1306 to 1644 1 to 339       339/339
(100 %)
0 diff
(100 %id)
AL578788 placenta .f 1460 to 2070 630 to 1       551/1067
(51 %)
31 diff
(97.1 %id)
BF804805 colon_ins .f 1475 to 1580 1 to 109       109/109
(100 %)
3 diff
(97.3 %id)
DB342756 thymus .f 1480 to 2076 597 to 1       597/597
(100 %)
5 diff
(99.2 %id)
FN068249 breast carcinoma .f 1537 to 1626 90 to 1     Submitted on the opposite strand 90/90
(100 %)
0 diff
(100 %id)
DB550074 hippocampus .f 1598 to 2074 1 to 477     Submitted on the opposite strand 477/477
(100 %)
8 diff
(98.4 %id)
R40024 whole brain .f 1736 to 2076 360 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 345/357
(96 %)
10 diff
(97.2 %id)
H05106 whole brain .f 1836 to 2078 256 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 245/245
(100 %)
4 diff
(98.4 %id)
Z41266 brain, total brain .f 1844 to 2076 233 to 1       233/233
(100 %)
1 diff
(99.6 %id)
NM_001164773.1   .g 1 to 1321 2 to 1322 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1322/1322
(100 %)
0 diff
(100 %id)
CB108015 Liver .g 34 to 439 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
BP316488 pericardium .g 34 to 614 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BM839221 Ascites, stomach .g 34 to 345 1 to 311       311/311
(100 %)
3 diff
(99.1 %id)
DC390866 Spleen .g 34 to 593 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BI224130 cervical carcinoma cell line, cervix .g 37 to 615 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BF684975 leiomyosarcoma cell line, uterus .g 43 to 844 1 to 812       812/887
(91 %)
11 diff
(98.8 %id)
BG335723 choriocarcinoma, placenta .g 43 to 844 1 to 797       797/982
(81 %)
32 diff
(96.8 %id)
AA308802 colon .g 44 to 513 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
BI763726 pooled colon, kidney, stomach .g 44 to 818 1 to 775       775/775
(100 %)
8 diff
(99.0 %id)
BM827191 Ascites, stomach .g 44 to 567 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
CA488747   .g 45 to 660 1 to 618       618/1110
(55 %)
14 diff
(98.8 %id)
TI_57150199   .g 46 to 818 32 to 804       773/804
(96 %)
12 diff
(98.6 %id)
BG477642 melanotic melanoma, skin .g 49 to 759 1 to 711       711/711
(100 %)
2 diff
(99.8 %id)
AF268048 placenta .g 51 to 1319 1 to 1269   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1269/1269
(100 %)
0 diff
(100 %id)
BI092046 cervix .g 51 to 668 1 to 619       619/620
(99 %)
6 diff
(99.1 %id)
BM824935 Ascites, stomach .g 51 to 587 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
AA078751 Pancreas .g 53 to 277 1 to 223       223/226
(98 %)
9 diff
(96.1 %id)
BG741046 skin .g 56 to 901 1 to 846       846/910
(92 %)
13 diff
(98.6 %id)
BG260575 bladder, transitional cell papilloma, cell line .g 58 to 840 1 to 778       778/1018
(76 %)
26 diff
(97.5 %id)
BE731433 choriocarcinoma, placenta .g 62 to 832 1 to 771       771/1065
(72 %)
8 diff
(99.3 %id)
BE731633 choriocarcinoma, placenta .g 63 to 844 1 to 788       788/1161
(67 %)
16 diff
(98.7 %id)
BE732989 choriocarcinoma, placenta .g 63 to 914 1 to 851       851/1100
(77 %)
24 diff
(97.9 %id)
BE733353 choriocarcinoma, placenta .g 63 to 836 1 to 771       771/771
(100 %)
3 diff
(99.7 %id)
BQ919957 epidermoid carcinoma, cell line, lung .g 63 to 967 1 to 913       913/917
(99 %)
11 diff
(98.9 %id)
BE276612 melanotic melanoma, skin .g 69 to 539 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BE891707 melanotic melanoma, skin .g 73 to 800 1 to 722       722/947
(76 %)
15 diff
(98.5 %id)
AA079825 Pancreas .g 917 to 1320 413 to 5       409/421
(97 %)
0 diff
(100 %id)
AK310101 Spleen .h 1 to 1449 1 to 1449 exact tiling clone,   1449/1449
(100 %)
1 diff
(100.0 %id)
BI222884 cervical carcinoma cell line, cervix .i 1 to 789 1 to 792 D192E D236G M237H A238G Q239S ... tiling clone,   792/792
(100 %)
5 diff
(99.4 %id)
CN260695 embryonic stem cells, cell lines H1, H7, andH9 .i 60 to 390 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
BU855429 ovary, teratocarcinoma, cell line .j 1 to 856 41 to 907       867/922
(94 %)
24 diff
(97.4 %id)
BU845150 ovary, teratocarcinoma, cell line .j 3 to 904 1 to 904 E237X L241P E242G L243A V244G ... tiling clone,   904/904
(100 %)
6 diff
(99.4 %id)
BU859240 ovary, teratocarcinoma, cell line .j 3 to 868 1 to 874   tiling clone,   874/912
(95 %)
14 diff
(98.5 %id)
BE744665 adenocarcinoma cell line, ovary .j 6 to 820 1 to 805       805/811
(99 %)
22 diff
(97.3 %id)
BE743150 adenocarcinoma cell line, ovary .j 7 to 329 1 to 329       329/1127
(29 %)
7 diff
(99.4 %id)
BE743786 adenocarcinoma cell line, ovary .j 7 to 867 1 to 857       857/942
(90 %)
31 diff
(96.8 %id)
BE740309 adenocarcinoma cell line, ovary .j 7 to 803 1 to 791   tiling clone,   791/795
(99 %)
8 diff
(99.0 %id)
BQ058887 lymph, lymphoma, cell line .k 1 to 948 1 to 953 E180G L190P W191L L192A Y193V ... tiling clone,   953/1065
(89 %)
15 diff
(98.6 %id)
AK023909 thyroid gland .l 1 to 2253 2 to 2254   tiling clone, available from FLJ,   2254/2254
(100 %)
4 diff
(99.9 %id)
AU141581 thyroid gland .l 1 to 569 2 to 570   capped   569/569
(100 %)
6 diff
(99.0 %id)
DB265867 uterus .l 52 to 242 2 to 192   capped   191/191
(100 %)
0 diff
(100 %id)
BQ708415 Spleen .l 146 to 931 1 to 793   tiling clone,   793/933
(84 %)
20 diff
(97.9 %id)
BU899300 Spleen .l 146 to 947 1 to 812       812/957
(84 %)
29 diff
(97.0 %id)
BQ712529 Spleen .l 146 to 954 1 to 823       823/925
(88 %)
18 diff
(98.1 %id)
BF934808 nervous_tumor .l 253 to 417 1 to 165       165/315
(52 %)
3 diff
(99.1 %id)
DA064658 cerebellum .l 523 to 1081 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AU159108 thyroid gland .l 1694 to 2253 560 to 1       560/566
(98 %)
20 diff
(96.5 %id)
DA085721 cerebellum .m 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
CV026343 mixed .m 63 to 613 1 to 551 G183R tiling clone,   551/553
(99 %)
2 diff
(99.7 %id)
DA540514 lung .n 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
3 diff
(99.5 %id)
DA481485   .o 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
BJ993209 hepatoblastoma .p 1 to 565 1 to 565 exact tiling clone, to resequence,   565/565
(100 %)
0 diff
(100 %id)
BM015445 breast, mammary adenocarcinoma, cell line .p 459 to 1117 1 to 661   tiling clone,   661/661
(100 %)
4 diff
(99.4 %id)
TI_59393684   .p 459 to 1117 50 to 710       661/661
(100 %)
4 diff
(99.4 %id)
BF912884 uterus_tumor .p 586 to 1052 1 to 467   tiling clone,   467/467
(100 %)
4 diff
(99.2 %id)
BP432761   .p 934 to 1154 39 to 260   tiling clone,   222/260
(85 %)
6 diff
(97.7 %id)
BJ993210 hepatoblastoma .p 1732 to 2197 466 to 1   tiling clone, to resequence,   466/466
(100 %)
1 diff
(99.8 %id)
BQ705967 Spleen .q 1 to 742 1 to 748 Q113X R117Q E118G L119A N121E ... tiling clone,   748/952
(78 %)
16 diff
(98.4 %id)
DA553248   .r 1 to 577 2 to 573   tiling clone, to resequence, capped   572/572
(100 %)
5 diff
(99.2 %id)
BX488337   .r 2 to 533 1 to 528   tiling clone,   528/528
(100 %)
8 diff
(98.5 %id)
DB249959 uterus .r 594 to 1153 2 to 561   tiling clone, capped   560/560
(100 %)
7 diff
(98.8 %id)
DB318415   .r 1834 to 2404 571 to 1   tiling clone, to resequence,   571/571
(100 %)
2 diff
(99.7 %id)
DB351049 uterus .r 1869 to 2404 536 to 1   tiling clone,   536/536
(100 %)
2 diff
(99.7 %id)
DA087637 cerebellum .s 1 to 574 2 to 575 exact tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
R91964 liver and spleen .t 1 to 391 1 to 397 L18X E39G L40V L41A E42G ... tiling clone,   397/423
(93 %)
13 diff
(97.0 %id)
AK310243 testis .u 1 to 1016 1 to 1016 exact tiling clone,   1016/1016
(100 %)
0 diff
(100 %id)
DC395685 testis .u 1 to 544 1 to 544       544/544
(100 %)
0 diff
(100 %id)
DC312303 alzheimer cortex .u 3 to 514 1 to 512       512/512
(100 %)
0 diff
(100 %id)
CB961737 placenta, pre-eclamptic placenta .va-u 1 to 692 27 to 726   tiling clone,   700/857
(81 %)
16 diff
(98.2 %id)
DA371446 thalamus .va-u 428 to 979 2 to 552 exact tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
EB386418 eye, optic nerve .vb-u 1 to 717 1 to 717 exact tiling clone,   717/717
(100 %)
1 diff
(99.9 %id)
BG027030 Bone, osteosarcoma, cell line .vb-u 216 to 906 1 to 690   tiling clone,   690/692
(99 %)
16 diff
(97.7 %id)
AA668711 ovary .vb-u 343 to 767 1 to 423   tiling clone, Submitted on the opposite strand 423/423
(100 %)
3 diff
(99.3 %id)
AI168201 pooled Gene BCAT2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI436684 pooled Gene BCAT2, variant not shown         Suspected internal deletion, this clone was ignored    
BE733115 choriocarcinoma, placenta Gene BCAT2, variant not shown         Suspected internal deletion, this clone was ignored    
DA876578 Prostate Gene BCAT2, variant not shown       capped This clone was ignored    
DB330151 Prostate Gene BCAT2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI